C4 Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
C4 Therapeutics Inc
TickerCCCC
CIK #0001662579
CUSIP12529R107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address490 Arsenal Way Suite 200, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2024
[0001662579] 10-K
[0001662579] 10-Q
[0001662579] 3
[0001662579] 4
[0001662579] 8-K
[0001662579] D
[0001662579] SC 13D
[0001662579] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Soleus Capital Master Fund LP C4 Therapeutics Inc [2023-04-14] 5.0
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2023-02-14] 11.85
ArrowMark Colorado Holdings LLC C4 Therapeutics Inc [2022-06-10] 11.09
Price T Rowe Associates Inc /MD/ C4 Therapeutics Inc [2022-02-14] 8.4
RTW Investments LP C4 Therapeutics Inc [2022-02-14] 5.1
BlackRock Inc C4 Therapeutics Inc [2022-02-04] 7.0
Perceptive Advisors LLC C4 Therapeutics Inc [2021-02-16] 7.3
Cobro Ventures Opportunity Fund LP C4 Therapeutics Inc [2020-10-16] 5.8
Cormorant Asset Management LP C4 Therapeutics Inc [2020-10-16] 1.21
Form 3/4/5 Filer 2011 - 2024
Grogan Donna Roy
C4 Therapeutics, Inc.
Dubin Glenn
Anderson Kenneth Carl
Boyle Scott N
Schick Kelly
White Lauren
Hirsch Andrew
Fisher Stewart
Siegel Jolie
Koppikar Utpal
Crystal Adam
Bessen Laura
Salter Malcolm
Cohen Marc A
Downey Bruce
Cohen Alain J
Prokupets Elena
Wahlberg Laura Jean
McKee William
Form 13F Holdings
Firm Period DFND Voting Shares
ArrowMark Colorado Holdings LLC [2023-03-31] SOLE 6,380,880.0 6,380,880.0
Wasatch Advisors LP [2023-03-31] SOLE 4,695,864.0 5,716,021.0
BlackRock Inc. [2023-03-31] SOLE 3,585,753.0 3,696,742.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 520,848.0 2,855,039.0
Soleus Capital Management LP [2023-03-31] SOLE 2,387,020.0 2,387,020.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,048,438.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 1,642,210.0 1,642,210.0
TCG Crossover Management LLC [2023-03-31] SOLE 1,250,000.0 1,250,000.0
Geode Capital Management LLC [2023-03-31] DFND 840,778.0 840,778.0
State Street Corp [2023-03-31] DFND 734,821.0 774,221.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 603,793.0 723,701.0
AQR Capital Management LLC [2023-03-31] DFND 584,293.0 606,465.0
Citadel Advisors LLC [2023-03-31] DFND 559,054.0 559,054.0
Two Sigma Advisers LP [2023-03-31] SOLE 341,400.0 400,300.0
Northern Trust Corp [2023-03-31] DFND 10,567.0 384,094.0
Nextech Invest Ltd [2023-03-31] SOLE 375,857.0 375,857.0
Nuveen Asset Management LLC [2023-03-31] DFND 356,609.0 356,609.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 330,967.0 347,239.0
Goldman Sachs Group Inc [2023-03-31] DFND 345,583.0 345,583.0
Renaissance Technologies LLC [2023-03-31] SOLE 57,563.0 326,080.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 317,009.0 317,009.0
Morgan Stanley [2023-03-31] DFND 211,802.0 294,138.0
Susquehanna International Group LLP [2023-03-31] DFND 268,067.0 268,067.0
Two Sigma Investments LP [2023-03-31] SOLE 263,264.0 263,264.0
Public Employees Retirement System of Ohio [2023-03-31] SOLE 197,045.0 197,045.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 192,203.0 194,161.0
GSA Capital Partners LLP [2023-03-31] SOLE 177,051.0 177,051.0
UBS Group AG [2023-03-31] DFND 0.0 162,650.0
Millennium Management LLC [2023-03-31] SOLE 153,556.0 153,556.0
Bank of New York Mellon Corp [2023-03-31] DFND 115,876.0 151,557.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com